Literature DB >> 7044129

A protease-like permeability factor in guinea pig skin: immunologic identity with plasma Hageman factor.

T Yamamoto, C G Cochrane.   

Abstract

Vascular permeability enhancement activity of the protease-like permeability factor derived from guinea pig skin and of active guinea pig Hageman factor (beta HFa) were both inhibited by anti-guinea pig Hageman factor rabbit F(ab')2 antibody. The permeability activity of both factors was also absorbed on anti-Hageman factor F(ab')2-Sepharose beads. The latent form of the permeability factor derived from skin extracts produced a single immunoprecipitation line with anti-Hageman factor and gave a reaction of identity with a precipitation band developing between purified Hageman factor and anti-Hageman factor. The latent permeability factor in the fraction corrected the clotting activity of Hageman-factor-deficient human plasma. The clotting activity was also blocked by anti-Hageman factor F(ab')2 antibody. From these results, it was concluded that the skin permeability factor was immunologically and functionally indistinguishable from Hageman factor of plasma. Extracts were obtained from skin of guinea pigs given intravenous injections of 125I-guinea pig Hageman factor immediately before sacrifice to calculate the amount of Hageman factor in the extravascular tissue space of the skin. The pseudoglobulin fractions of the extracts containing a concentration of Hageman factor of approximately 9 microgram of Hageman factor per gram of skin. This was determined both by immunologic means and procoagulant activity. Only 4% of the Hageman factor in the extract was obtained from the intravascular plasma volume of the skin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7044129      PMCID: PMC1916013     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  Vascular permeability factors (PF/Nat and PF/Dil)--their relationship to Hageman factor and the kallikrein-kinin system.

Authors:  S Oishi; M E Webster
Journal:  Biochem Pharmacol       Date:  1975-03-01       Impact factor: 5.858

2.  A protease-like permeability factor in the guinea pig skin. 2. In vitro activation of the latent form permeability factor by weakly acidic phosphate buffer.

Authors:  T Yamamoto; K Kozono; T Kambara
Journal:  Biochim Biophys Acta       Date:  1978-08-17

3.  A protease-like permeability factor in the guinea pig skin. 1. Partial purification and characterization.

Authors:  T Yamamoto; T Kambara
Journal:  Biochim Biophys Acta       Date:  1978-04-19

4.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

5.  Simple method for quantitation of enhanced vascular permeability.

Authors:  K Udaka; Y Takeuchi; H Z Movat
Journal:  Proc Soc Exp Biol Med       Date:  1970-04

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Plasma-kinin-forming enzyme in human skin: extraction and column chromatographic separation of plasma-kinin-forming enzyme and its inhibitor.

Authors:  N Toki; T Yamura
Journal:  Acta Derm Venereol       Date:  1978       Impact factor: 4.437

8.  The relationship between PF-DIL and activated human Hageman factor.

Authors:  A R Johnston; C G Cochrane; S D Revak
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

Review 9.  Molecular assembly in the contact phase of the Hageman factor system.

Authors:  C G Cochrane; J H Griffin
Journal:  Am J Med       Date:  1979-10       Impact factor: 4.965

10.  Kinin-forming enzyme in human skin: the purification and characterization of a kinin-forming enzyme.

Authors:  N Toki; T Yamura
Journal:  J Invest Dermatol       Date:  1979-10       Impact factor: 8.551

View more
  8 in total

1.  Fifth component of complement (C5)-derived high-molecular-weight macrophage chemotactic factor in normal guinea pig serum.

Authors:  I Kukita; T Yamamoto; T Kawaguchi; T Kambara
Journal:  Inflammation       Date:  1987-12       Impact factor: 4.092

2.  Activation of factor XII-dependent pathways in human plasma by hematin and protoporphyrin.

Authors:  C G Becker; M Wagner; A P Kaplan; M Silverberg; R W Grady; H Liem; U Muller-Eberhard
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

3.  Guinea pig plasma kallikrein as a vascular permeability enhancement factor. Its dependence on kinin generation and regulation mechanisms in vivo.

Authors:  T Imamura; T Yamamoto; T Kambara
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

4.  A serratial protease causes vascular permeability reaction by activation of the Hageman factor-dependent pathway in guinea pigs.

Authors:  R Kamata; T Yamamoto; K Matsumoto; H Maeda
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

5.  The chemical mediation of delayed hypersensitivity skin reactions. IV. Activation of chemotactic factor precursor by a trypsin-like protease in guinea pig plasma.

Authors:  T Kawaguchi; K Ueda; T Yamamoto; T Kambara
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

6.  A high-molecular-weight trypsinlike protease in the skin sites of delayed hypersensitivity in guinea pigs.

Authors:  T Nakamura; T Yamamoto; T Ishimatsu; T Kambara
Journal:  Am J Pathol       Date:  1984-02       Impact factor: 4.307

7.  Guinea pig macroalbumin. A major inhibitor of activated Hageman factor in plasma with an alpha 2-macroglobulin-like nature.

Authors:  T Ishimatsu; T Yamamoto; K Kozono; T Kambara
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

8.  The role of Pseudomonas aeruginosa elastase in corneal ring abscess formation in pseudomonal keratitis.

Authors:  Y Ijiri; T Yamamoto; R Kamata; H Aoki; K Matsumoto; R Okamura; T Kambara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-09       Impact factor: 3.535

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.